An extension of clinical responsibility in the direction of preventive responsibility is generally accepted as proper, even though it is slow in being applied. When someone with symptomless hypertension is given hypotensive drugs with the object of reducing the risk of stroke, that is preventive medicine. The subject having made no complaint is not strictly a patient: but the clinician accepts a responsibility for him because of the high risk that he will become a patient if nothing is done. This is an analogy for our concern with identifying subjects with a high coronary risk, and the attempt in such persons to prevent the onset of major ischaemia.
powerful available predictors of myocardial infarction and CHD death. The main primary risk factors are of undiminished importance in such persons, but screening for myocardial ischaemia is not recommended without evidence that intervention at this late stage is effective.
Estimates are presented of the relative importance to individuals of the main primary risk factors. Their importance as population risk factors is different, depending on the product of attributable risk and prevalence: a high risk with low prevalence, as from severe hypercholesterolaemia, is of small importance compared with that arising from the numerous individuals with smaller elevations. Most cases of CHD arise from the common and therefore inconspicuous combination of slight increases in two or three factors in the same individual. Selective and opportunistic risk factor screening is recommended, not a general service.
An extension of clinical responsibility in the direction of preventive responsibility is generally accepted as proper, even though it is slow in being applied. When someone with symptomless hypertension is given hypotensive drugs with the object of reducing the risk of stroke, that is preventive medicine. The subject having made no complaint is not strictly a patient: but the clinician accepts a responsibility for him because of the high risk that he will become a patient if nothing is done. This is an analogy for our concern with identifying subjects with a high coronary risk, and the attempt in such persons to prevent the onset of major ischaemia.
Minor ischaemia as a risk factor for major disease
The most effective way to predict myocardial infarction and death from coronary heart disease (CHD) is by evidence of early myocardial ischaemia. For example, in various population studies resting electrocardiography has been used, together with a simple self-administered questionnaire which identifies angina or history of possible infarction. Figure  1 illustrates typical findings: there are indications of ischaemia (positive ECG or suggestive symptoms) in perhaps 160/103 middle-aged working men, among whom the annual rate of developing major coronary heart disease proves to be substantially higher than in those whose examination is negative. A simple screening examination of this kind is able to give advance warning in almost 50 % of all the men who will suffer a major coronary event in the next 5 years. Prediction becomes even more powerful if the examination is repeated annually, since these markers of early ischaemia are often transitory: a man may be positive one year, negative the next and the following year have a fatal infarction. Myocardial infarction and CHD death are rarely unheralded, but the warnings are often unobserved.
There is an opposite and equally important way of regarding these data. Among men with minor ischaemia the relative risk is high; but in the short or medium term the risk in absolute terms is quite low, and 5 years later 80-90 % of them will be alive and well. Those who advocate routine screening for myocardial ischaemia must consider the numerous false alarms involved. If a man is told that his ECG gives cause for concern, he will never forget it. Anxiety 35-39.) can be reduced by proper explanation but not abolished, and it can only be justified by good evidence that the inevitable harm can be offset by a corresponding hope of benefit. It is only proper to uncover a high risk state if risk is known to be reversible. At the stage when myocardial injury has occurred, it must be asked whether the process may not have advanced too far to be effectively slowed.
There is recent evidence showing that even in those individuals who have progressed to this stage of early ischaemic injury, the main primary risk factors (smoking and the levels of blood pressure and cholesterol) are still major predictors of the outcome. Thus each of these factors seems to increase the risk of CHD death at least as much in men with, for example, ischaemic S-T/T changes as in the rest. This is certainly encouraging for the possibility of prevention being effective even at this late stage, but it still needs a controlled trial to discover the effect of modifying risk factors in this important group. Until this has been done it would not be right to press screening for early myocardial ischaemia. However, whenever such evidence of ischaemia happens to come to a doctor's notice, it should underline the urgency of controlling the primary risk factors.
Primary risk factors
Of the primary risk factors age is the strongest predictor: CHD incidence doubles in middle-aged people every 7 or 8 years. On the other hand, the older the person being dealt with, the less the urgency of preventive action, because the tragedy of an early death is felt more strongly as compared with death in old age.
Male sex is also a powerful identifier of risk, although the mortality rates for CHD in the two sexes converge steadily throughout life and eventually they almost meet. It would nevertheless be well to consider that if CHD did not occur at all in men, then it would be reckoned a terrible scourge among women. Women are not really at low risk: their problem is simply overshadowed by the extremely high risk in men.
There are three key factors for identifying persons with a special need for preventive advice, and these happen also to be the three factors on whose modification it is desirable to concentrate: they are smoking, blood pressure and blood cholesterol. Table 1 shows their relative power as risk factors in middleaged men, taking as unity the risk in the happy individual who does not smoke and who has low levels of blood pressure and cholesterol. Risk is approximately doubled by either fifteen cigarettes daily or by 20 mm elevation of diastolic pressure or by a cholesterol level of 250 mg/dl. Each of these is roughly equivalent in its effect on risk.
Clinical interest in identifying high risk has been Figure 2 shows first a graph (the broken line) relating CHD mortality to cholesterol level at entry to the study. The base of this scale is set at the level of risk for men in the lowest cholesterol class, so that the height above the base at each level of cholesterol represents the excess or attributable risk. Concern is commonly concentrated on individuals in the upper cholesterol classes, where the risk of CHD is admittedly high. However, a strategy of community control must consider not only the risk in any particular group of individuals, but also the number of such persons in the population. These prevalence values are shown in the histogram (Fig. 2) . By simple cross-multiplication of the prevalence rates with the corresponding individual attributable risks one may calculate 'population attributable risk'. The results, which are shown as numbers at the top of each bar in the histogram, represent the actual numbers of CHD deaths in this population group which are statistically attributable to each particular level of cholesterol elevation. It is seen that out of the total of fourteen CHD deaths/103/10 years which are statistically attributable to cholesterol elevation, only one arises in those levels (>310 mg/dl, 8 mmol/l) that are likely to arouse clinical concern, whereas seven (50%) arise at levels below 250 mg/dl (6 5 mmol/l): up to more than 1000% because the factors are intercorrelated.) These represent the proportion by which CHD mortality would fall in this population if one could abolish the whole of the risk associated statistically with that factor, that is, the theoretical maximum contribution from a wholly effective control programme; and they are calculated from products of individual risk and prevalence rates. These results permit comparison of the relative importance of the various risk factors in this particular population; they emphasize the dominating importance of blood pressure as a population risk factor for CHD.
The final column of Table 2 shows the cut-off point in the distribution of each risk factor such that about one-third of attributable cases arise above that level and two-thirds below it. In each instance it is seen that only a small community benefit can be expected if preventive action is restricted to individuals who lie in the upper extreme of the distribution for a single risk factor.
Multifactorial risk
There is substantial though not complete independence between the main risk factors, so that the risk for a man with two factors is not far short of the product of the two separate relative risks. This means that the absolute risk associated with a particular factor is not the same for everyone but depends on the context in which it occurs: it is thus essential to assess an individual's profile as a whole. An example of this is illustrated in Table 3 , which is derived from Framingham data for 50-year-old men: it shows that the excess CHD risk associated with cigarette smoking is more than three times greater in the presence of higher levels of blood pressure and cholesterol. A similar effect holds for other combinations of the main risk factors.
In an earlier paper in this symposium Professor Blackburn (1976) has shown the necessity of a multifactorial approach to risk identification, following 
